1. Search Result

Search Result

Results for "306959-01-3" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-136446

    Others Cancer Cardiovascular Disease
    MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression.